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Abstract: High prevalence of premature coronary heart disease in Pakistanis compared to other populations points 
towards the genetic predisposition of this population to develop this disease. Since no investigations have been carried 
out in Pakistan to study the relationship of polymorphisms in genes involved in homocysteine cycle, the objective of the 
present study was to find out if there is any association of methylenetetrahydrofolate reductase (MTHFR) C677T, 
A1298C; methionine synthase (MS) A2756G; cystathionine-β-synthase (CBS) 844ins68, G919A polymorphisms with 
premature acute myocardial infarction (AMI) in a population of Pakistani patients with this disease. In a cross-sectional 
study, DNA samples of 143 AMI patients (age <45 years) and 153 healthy controls were genotyped for the above 
mentioned polymorphisms using PCR-RFLP methods. Plasma/serum samples of both patients and healthy controls were 
screened for homocysteine, folate and vitamin B12. One way ANOVA and chi-squared test were used for analysis of 
data. Mean plasma homocysteine levels in premature AMI patients and healthy controls were found to be 23±17.2 and 
23±13.4 µmol/l, respectively which are higher than the upper normal limit of this biomarker (15µmol/l). MTHFR 677 CT 
genotype in healthy controls and MTHFR 677 TT genotype in AMI patients were found to have significantly increased 
levels of plasma homocysteine (p value <0.05), while all other polymorphisms did not show any significant difference in 
mean levels of homocysteine between AMI patients and healthy controls. Moreover, no association was observed 
between MTHFR C677T, A1298C; MS A2756C; CBS844ins68 polymorphisms and premature AMI in this population. 
This indicates that common polymorphisms in MTHFR, MS and CBS genes have no role in premature AMI in Pakistani 
population. 
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INTRODUCTION 
  
There is a high prevalence of premature coronary artery 
disease in Pakistani population. In a previous study 
conducted at the Aga Khan University, it was shown that 
sixteen percent of all the acute myocardial infarction 
(AMI) patients admitted at its hospital during the 3-year 
period between 2000 to 2002 were less than 45 years old 
(Saleheen and Frossard, 2004). A comprehensive survey 
carried out in Pakistan showed that average age of 
Pakistani patients with myocardial infarction (MI) is 10 
years lower compared to Caucasian MI patients in the 
West (Jafary et al., 2007). Recent reports from South 
Asian region have indicated hyperhomocysteinemia to be 
associated with young AMI patients in Bangladesh 
(Karim et al., 2015) and India (Kaur et al., 2016). Another 
study showed hyperhomocysteinemia to be very common 
amongst young (below 40 years) AMI patients from 
Western India and folate deficiency appeared to be the 
major cause for higher levels of fasting plasma 
homocysteine (Ghosh et al., 2007). This clearly showed 
an association of plasma homocysteine with AMI in 
young South Asian populations and vitamin B 
deficiencies appeared to be causing 
hyperhomocysteinemia. This association of plasma 
homocysteine with AMI has also been reported in a 
Turkish population (Akyürek et al., 2014). While B 
vitamin deficiencies and hyperhomocysteinemia have 
been shown to be associated with AMI in Pakistani adults 
(Iqbal et al., 2005), only a few investigations have been 
carried out in South Asia to study the association of 
polymorphisms in genes of enzymes involved in 
homocysteine metabolism with AMI (Iqbal et al., 2005; 
Ghosh et al., 2007; Iqbal et al., 2011). However, no study 
has been carried out to find out the relationship of 
polymorphisms in methylenetetrahydrofolate reductase 
(MTHFR), methionine synthase (MS) and cystathionine 
beta synthase (CBS) genes and AMI in Pakistani 
population. The present study aims at investigating the 
relationship of polymorphisms in these three genes of 
homocysteine cycle with premature AMI in a Pakistani 
population in Karachi. 
  
MATERIALS AND METHODS 
  
Two hundred and three consecutive adult patients with 
first episode of AMI (age range from 18-45 years) *Corresponding author: e-mail: perwaiz.iqbal@aku.edu 
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admitted at the National Institute of Cardiovascular 
Diseases (NICVD), Karachi were recruited with written 
informed consent. They had the confirmed diagnosis of 
AMI. The details of the WHO criteria for diagnosis and 
the inclusion and exclusion criteria have been published 
previously (Iqbal et al., 2013). Similarly, 205 healthy 
controls who had been matched for gender and age 
(within 3 years) were also enrolled with written informed 
consent. Controls were recruited from the personnel of the 
Aga Khan University and other health care institutions in 
Karachi. Inclusion and exclusion criteria of these controls 
have been mentioned in detail in a previous paper (Iqbal 
et al., 2013). The study had been approved by the Ethical 
Review Committee of the Aga Khan University. 
  
Ten ml of venous blood with at least 10 hours of fasting 
was collected and divided into two equal parts. One part 
was transferred to a heparinized tube and the other part 
into a plain tube. Plasma/serum was obtained for 
determination of homocysteine and folate using kit 
methods (Roche Diagnostics, USA), while serum 
concentration of vitamin B12 was determined using a 
radio assay (Quadros, 2000). DNA was extracted from 
leukocytes using standard protocols (Sambrook et al., 
1989). Genotyping of MTHFR C677T, A1298C; MS 2756; 
CBS 844ins68, G919A polymorphisms was done using 
polymerase chain reaction and restriction fragment length 
polymorphism (PCR-RFLP) methods. The details of 
primers and restriction enzymes have been mentioned in a 
previous paper (Yakub et al., 2012). 
  
All analyses were conducted using the software SPSS® 
(Statistical Package for Social Sciences) version 13 for 
Windows® (Apache Software Foundation, USA). All the 
continuous variables such as homocysteine, folate, 
vitamin B12, age and body mass index (BMI) were 
expressed as mean ±SD. Hardy-Weinberg proportions of 
genotype distributions were tested by using Hardy-
Weinberg equilibrium calculator (Rodriguez et al., 2009). 
The mean differences in the values of homocysteine, 
folate and vitamin B12 across various genotypes were 
assessed using one way ANOVA. A post-hoc test was 
carried out for multiple pair-wise comparisons. All p 
values less than 0.05 were considered significant. 
  
RESULTS 
  
Although we had recruited 203 patients with premature 
AMI and 205 healthy subjects as controls, yet the 
complete genotyping for all 5 polymorphisms could be 
obtained for 143 AMI patients and 154 healthy controls. 
Therefore, all our results are with this sample size. As 
shown in table 1, no significant differences were found in 
age, BMI, and plasma/serum concentrations of 
homocysteine and vitamins folate and B12 between 
premature AMI patients and healthy controls. Frequency 
distribution of genotypes of SNPs in AMI patients and 
healthy controls indicates that all polymorphisms 
investigated in this study, except for CBS 844ins68 in 
AMI patients, were found to occur in Hardy-Weinberg 
equilibrium (table 2). 
  
Genotyping of CBS G919A polymorphism revealed that 
all AMI patients and healthy controls were GG genotype 
and, therefore, were not subjected to analysis. The 
percentages of genotypes for the 4 polymorphisms 
(MTHFR 677CC, CT, TT; MTHFR 1298AA, AC, CC; 
CBS 844ins68 WW, WI, II; MS 2756 AA, AG, GG) in 
AMI patients and healthy controls when compared by chi-
squared analysis showed no significant difference 
indicating that there is no association of these 
polymorphisms with premature AMI in this population. 
  
Mean concentrations of plasma homocysteine with 
respect to various genotypes of healthy controls and AMI 
patients have been shown in table 3. Significant 
differences in mean levels of homocysteine were observed 
in MTHFR C677T polymorphism. MTHFRCT genotype 
and MTHFR TT genotype in healthy controls and AMI 
patients, respectively were found to have significantly 
increased levels of plasma homocysteine (p<0.05). This 
indicates that MTHFR 677T allele is the determinant of 
plasma homocysteine. However, no significant difference 
was found among the genotypes of the other 3 
polymorphisms (MTHFR A1298C, CBS 844ins68, MS 
A2756G). Serum folate and vitamin B12 levels were not 
found to be associated with any genotype of the four 
polymorphisms investigated in this study (table4). 
 
DISCUSSION 
  
High prevalence of AMI in young Pakistani population 
points towards a possible genetic predisposition of this 
population to developing coronary artery disease (CAD). 
Association of certain polymorphisms in paraoxonase 
gene cluster with MI in Pakistani population has already 
been reported (Saeed et al., 2007). Moreover, evidence 
regarding association of the 9p21.3 locus with risk of 
AMI in Pakistanis lent further support to genetic 
predisposition of this population to CAD (Saleheen et al., 
2010). Since hyperhomocysteinemia, an established risk 
factor for atherosclerosis is very much prevalent in 
Pakistani general population (Yakub et al., 2010), it is 
conceivable that polymorphisms in genes (such as 
MTHFR, MS and CBS) involved in homocysteine 
metabolism could be contributing to increased risk of 
premature AMI in this population. 
  
Results of the present study however, show that none of 
these polymorphisms has any association with premature 
AMI in Pakistani population. Mean plasma homocysteine 
levels were high both in AMI patients as well as healthy 
controls. The percentage of MTHFR TT genotype – a 
major factor for hyperhomocysteinemia in most 
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populations was found to be very low in both AMI 
patients and healthy controls (4.2% and 1.9%, 
respectively). These findings are in line with previous 
reports that TT variant does not appear to play any 
significant role in high prevalence of 
hyperhomocysteinemia in South Asian populations 
(Markan et al., 2007; Michael et al., 2009; Yakub et al., 
2012). A study in Cyprus showed that even in populations 
with high prevalence of MTHFR TT genotype in both 
AMI patients and healthy controls (17.7% vs. 19.2%, 
respectively), MTHFR polymorphism appeared to have no 
association with AMI in young Cypriots (Eftychiou et al., 
2012). 
  
The percentages of CBS 844ins66 heterozygotes among 
AMI patients and healthy controls (9.8% and 13.6%, 
respectively) merit some discussion. These values of 
heterozygosity are similar to the values observed in 
Iranian population (12.3%), Indian population (7.97%), 
Italian population (7.8%), US population (11.2%) and 
Turkish population (11.8%), (de Franchis et al., 2000; 
Dutta et al., 2005; Senemar et al., 2009; Koc and Akar, 
2009), but different from Japanese, Chinese and 
Indonesian populations where it has been found to be 
absent (Dutta et al., 2005). Kluijtmans et al., (1997) have 
reported this insertion to be present in nearly equal 
proportions in both patients with premature arterial 
occlusive disease and controls. Furthermore, the insertion 
variants were not associated with hyperhomocysteinemia. 
Our results corroborate these findings and the insertion 
variants were neither associated with AMI nor with 
increased levels of plasma homocysteine. 
  
Lack of association of CBS 844ins68, MS A2756G and 
MTHFR C677T polymorphisms with AMI in Pakistani 
population observed by us is also supported by results of a 
Table 1: Demographic and clinical characteristics of patients with premature AMI and age and gender-matched 
healthy controls 
 
Variable AMI patients (n=143) Controls (n=154) p value 
Age (years) 41.3±5.0 41.0±5.0 0.61 
Body Mass Index (BMI) 25.5±4.3 25.1±4.0 0.396 
Homocysteine (µmol/l) 23.0±17.2 23.0±13.4 0.985 
Vitamin B12 (pg/ml) 320±189 333±168 0.536 
Folate (ng/ml) 6.71±3.7 6.11±2.84 0.120 
Mean ± SD 
 
Table 2: Frequency distribution of genotypes of polymorphisms in genes associated with homocysteine metabolism in 
healthy controls and AMI patients 
 
SNP Genotype  N (%) 
    Healthy controls (n=154) X2 HWEP AMI patients (n=143) X2 HWEP 
MTHFR C677T CC 118(76.6)   103(72.0)   
  CT 33(21.4) 0.15 NS 34(23.7) 2.03 NS* 
  TT 3(1.9)   6(4.2)   
          
          
MTHFR A1298C AA 37(24.0)   32(22.4)   
  AC 86(55.8) 2.17 NS 63(44.1) 1.66 NS 
  CC 31(20.1)   48(33.6)   
          
          
CBS 844ins68**  WW 132(85.7)   127(88.8)   
  WI 21(13.6) 0.03 NS 14(9.8) 4.13 <0.05 
  II 1(0.6)   2(1.4)   
          
          
MS A2756G AA 75(48.7)   88(61.5)   
  AG 67(43.5) 0.31 NS 45(31.5) 1.55 NS 
  GG 12(7.8)   10(7.0)   
Note: Hardy-Weinberg equilibrium (HWE) testing is shown in this table. Except for CBS 844ins68 polymorphism in AMI patients, 
all other polymorphisms (MTHFR C677T; MTHFR A1298C and MS A2756G) were in HWE in both AMI patients and control 
groups. *NS indicates “not significant”. **WW: Homozygous wild (ancestral); WI: Wild (ancestral)/Insertion heterozygous; II: 
Insertion homozygous variant. 
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study carried out on Southern Chinese Han population in 
which no relationship was found between these 3 
polymorphisms and ischemic cardiovascular disease (Dai 
and Zhang, 2001). These observations support the notion 
that plasma homocysteine alone does not appear to play 
any significant role in increasing the risk of AMI in 
Pakistani population. 
Our results should be viewed in the context of a limitation 
of this study. Information about the use of medications by 
the recruited subjects was not part of our questionnaire. In 
a large clinical trial, it has been shown that statin 
treatment is protective against coronary heart disease in 
subjects with MTHFR 677 CC genotype (0.71(95% CI 
0.58-0.87) and CBS 844ins68 insertion variants 
Table 3: Plasma concentration of homocysteine with respect to various genotypes of healthy controls and premature 
AMI patients 
 
SNP& Genotype Healthy controls (n=154) AMI patients (n=143) Homocysteine (µmol/l) ANOVA p value Homocysteine (µmol/l) ANOVA p value 
MTHFR 677         
CC 21.4±9.9   22.2±14.3   
CT 28.3±21.2* 0.03 21.6±10.3 0.006 
TT 23.0±13.4   44.0±53.9**   
MTHFR 1298         
AA 23.4±12.4   21.3±10.4   
AC 23.9±14.8 0.363 22.9±14.5 0.752 
CC 19.9±10.2   24.2±23.2   
CBS 844ins68         
WW 23.0±14.1   23.4±18.0   
WI 22.8±8.9 0.937 19.3±7.5 0.703 
II 27.8   23.7±9.0   
MS 2756         
AA 23.1±14.8   23.9±18.4 0.593 
AG 22.1±10.8 0.402 22.1±16.1   
GG 27.8±17.7   18.5±7.8   
*Significantly different from CC genotype when analyzed by Tukey’s HSD test for multiple pair-wise comparison (p=0.026). 
**Significantly different from CC and CT genotypes when analyzed by Tukey’s HSD test for multiple pair-wise comparison 
(p<0.01). 
 
Table 4: Serum concentrations of folate and vitamin B12 with respect to various genotypes of healthy controls and 
AMI patients 
 
SNP Healthy controls (n=154) AMI patients (n=143) 
  Folate  
(ng/ml) 
ANOVA 
p value 
B12 
(pg/ml) 
ANOVA 
p value 
Folate  
(ng/ml) 
ANOVA 
p value 
B12 
(pg/ml) 
ANOVA  
p value 
MTHFR 677                 
CC 6.2±2.9   340±173   6.5±3.3   324±203   
CT 5.6±2.6 0.57 303±150 0.298 7.2±4.9 0.61 308±156 0.96 
TT 5.9±2.9   440±199   7.4±3.4   324±114   
MTHFR 1298                 
AA 6.5±2.8   323±173   7.5±3.9   310±249   
AC 5.9±2.8 0.539 329±162 0.735 6.4±3.6 0.401 327±163 0.918 
CC 6.0±2.9   354±199   6.5±3.8   318±180   
CBS 844ins68*                 
WW 6.1±2.9   333±173   6.7±3.7   328±192   
WI 5.9±2.4 0.84 339±146 0.79 6.3±4.1 0.93 253±168 0.39 
II 4.8±0   220±0   6.8±3.8   280±57   
MS 2756                 
AA 6.1±0.3   342±181   6.7±3.7   339±210   
AG 6.1±2.4 0.98 331±149 0.6 6.3±3.0 0.16 281±141 024 
GG 5.9±3.4   291±190   8.7±6.0   330±173   
*WW: Homozygous wild (ancestral); WI: Wild (ancestral)/Insertion heterozygous; II: Insertion homozygous variant. 
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(0.58(95% CI 0.44-0.78) (Maitland-van der Zee et al., 
2008). Therefore, statin users with the above mentioned 
genotypes could have been protected from having AMI 
episode and, hence, were not included as AMI patients. 
This notion is supported by the observation that the 
proportions of MTHFR 677 CC genotype and the CBS 
844ins68 insertion variants are less (though non-
significant) in AMI patients compared to healthy controls 
(72.0% vs. 76.6.0% and 9.8% vs.13.6%, respectively) in 
the study population. 
  
Large prospective studies with complete information of 
medications used by the participants would be required to 
ascertain the relationship of these polymorphisms with 
AMI in Pakistani population. 
 
CONCLUSION 
  
Most common polymorphisms in MTHFR, MS and CBS 
genes are not associated with premature AMI in a 
Pakistani population. 
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